A systematic review of vitiligo onset and exacerbation in patients receiving biologic therapy

• Muskaan Sachdeva, BHSc,
• Asfandyar Mufti, MD,
• Nadia Kashetsky, MSc,
• Jorge R. Georgakopoulos, MD,
• Sheida Naderi-Azad, BSc,
• Jennifer Salsberg, MD, FRCPC,
• Jensen Yeung, MD, FRCPC

Affiliations

Muskaan Sachdeva, BHSc

Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada

Asfandyar Mufti, MD

Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada

Nadia Kashetsky, MSc

Faculty of Medicine, Memorial University, St. John's, Newfoundland and Labrador, Canada

Jorge R. Georgakopoulos, MD

Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada

Sheida Naderi-Azad, BSc

Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada

Jennifer Salsberg, MD, FRCPC

Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Women's College Hospital, Toronto, Ontario, Canada

Jensen Yeung, MD, FRCPC

Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada; Women's College Hospital, Toronto, Ontario, Canada; Probity Medical Research Inc., Waterloo, Ontario, Canada; Correspondence to: Jensen Yeung, MD, FRCPC, Women's College Hospital, Division of Dermatology, 76 Grenville St, 5th floor, Toronto, ON M5S 1B2, Canada